Kabra Drugs Ltd share price logo

Kabra Drugs Ltd

BSE: 524322

Small Cap

Pharma Sector

₹26.89

+3.26

(+13.80%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Project Approval Alert

Kabra Drugs receives government approval for ₹200 crore drug manufacturing project in Chhattisgarh.

Kabra Drugs Stock Performance

as on June 15, 2026 at 8:49 pm IST

  • Day's Low

    Day's High

    ₹25.25
    ₹28.35
    downward going graph

    6.10%

    Downside

    5.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹12.21
    ₹35.52
    downward going graph

    54.59%

    Downside

    32.09%

    Upside

    downward going graph

Kabra Drugs share price movements today

Previous Close
₹23.63
Open
₹26.89
Volume
3.66L
Upper Circuit
₹28.35
Lower Circuit
₹18.91
Day's Low - High
₹25.25 - ₹28.35
52 Week Low - High
₹12.21 - ₹35.52

Kabra Drugs Historical Returns

1 Month Return
-5.4 %
3 Month Return
-18.57 %
1 Year Return
+ 93.53 %
3 Year Return
+ 337.59 %
5 Year Return
+ 350.1 %

Kabra Drugs Fundamentals

as on June 15, 2026 at 3:19 pm IST

Market Cap

₹1,312.32 Cr

Return on Equity (ROE)

15.9

PE Ratio (TTM)

59.94

Return on capital employed (ROCE)

21.76

Beta (LTM)

0.58

P/B Ratio

15.17

Dividend Yield

0

PEG Ratio

194.62

Quarterly Earnings Growth YOY

171.79

EPS (TTM)

0

Book Value

0

Kabra Drugs Technical Analysis

Track how Kabra Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish9
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
0.03
Bullish
CCI (20)
-3.84
Neutral
RSI (14)
54.77
Neutral
Momentum (10)
0.27
Neutral
ADI (14)
20.03
Neutral
Ultimate Oscillator (7,14,28)
53.13
Neutral

Moving Averages

Name

Value

Action

SMA (20)
26.83
Bullish
EMA (20)
26.84
Bullish
VWMA (20)
26.85
Bullish
SMA (50)
26.8
Bullish
EMA (50)
26.8
Bullish
SMA (200)
26.77
Bullish
EMA (200)
26.7
Bullish
KAMA (200)
26.77
Bullish
DEMA (200)
27
Bearish

Kabra Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kabra Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,312.321853.12%0.00932
Biofil Chemicals & Pharmaceuticals Ltd image
Biofil Chemicals & Pharmaceuticals Ltd
NA58.98-9.75%0.00NA33
Brooks Laboratories Ltd image
Brooks Laboratories Ltd
NA196.07-6.56%0.54-1082
Haleos Labs Limited image
Haleos Labs Limited
NA425.1324.2%0.6818344
Tyche Industries Ltd image
Tyche Industries Ltd
NA130.02-8.47%0.001265
See all

Kabra Drugs Stock’s Investor Sentiment and Interest

Search interest for Kabra Drugs Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Kabra Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
-
-
-
-
-
-
-
-
7.15
19.76
30.42
35.41
Other Income
-
-
-
-
-
-
-
0.64
0.02
0.18
0.18
0.11
Total Income
-
-
-
-
-
-
-
0.64
7.17
19.94
30.6
35.52
Expenses
0.12
0.13
0.11
0.37
0.55
0.4
0.53
0.24
7.66
17.73
27.99
34.07
Operating Profit
-0.12
-0.13
-0.11
-0.37
-0.55
-0.4
-0.53
-0.24
-0.51
2.03
2.43
1.34
Operating Profit Margin %
0%
0%
0%
0%
0%
0%
0%
0%
-7.13%
10.27%
7.99%
3.78%
Profit Before Interest, Tax and Depreciation
-0.12
-0.13
-0.11
-0.37
-0.55
-0.4
-0.53
0.4
-0.5
2.22
2.62
1.45
Interest
-
-
-
-
-
-
-
-
-
-
-
0.01
Depreciation
-
-
-
-
-
-
-
0.01
-
0.01
0.01
0.02
Profit Before Tax
-0.12
-0.13
-0.11
-0.37
-0.55
-0.4
-0.53
0.39
-0.5
2.21
2.61
1.42
Tax Paid
-
-
-
-
-
-
-
-
-
0.37
0.04
0.36
Profit After Tax
-0.12
-0.13
-0.11
-0.37
-0.55
-0.4
-0.54
0.39
-0.5
1.84
2.57
1.06
Total Net profit including share of profit / Loss from associate company
-0.12
-0.13
-0.11
-0.37
-0.55
-0.4
-0.54
0.39
-0.5
1.84
2.57
1.06
EPS
-0.28
-0.31
-0.25
-0.84
-1.24
-0.39
-0.53
0.21
-0.21
0.77
1.08
0.45
Actual EPS
-0.28
-0.31
-0.25
-0.84
-1.24
-0.39
-0.53
0.21
-0.21
0.77
1.08
0.45
Adjusted EPS
-0.28
-0.31
-0.25
-0.84
-1.24
-0.39
-0.53
0.21
-0.21
0.77
1.08
0.45
Diluted EPS
-0.28
-0.31
-0.25
-0.84
-1.24
-0.39
-0.53
0.21
-0.21
0.77
1.08
0.45

Kabra Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
2.01
-
-
-
-
-
-
-
92.74
Other Income
0.01
-
-
-
-
-
-
0.64
0.49
Total Income
2.02
0.01
0.02
-
-
0.01
-
0.64
93.23
Expenses
3.99
0.14
0.05
0.15
0.18
0.34
0.74
1.72
87.41
Operating Profit
-1.98
-0.14
-0.05
-0.15
-0.18
-0.34
-0.74
-1.72
5.33
Operating Profit Margin %
-98.51%
0%
0%
0%
0%
0%
0%
0%
5.75%
Profit Before Interest, Tax and Depreciation
-1.97
-0.13
-0.03
-0.15
-0.18
-0.34
-0.74
-1.08
5.82
Interest
0.25
0.01
0.03
-
-
-
-
-
0.03
Depreciation
0.14
0.03
-
0.03
0.01
-
-
0.01
0.07
Profit Before Tax
-2.36
-0.17
-0.06
-0.18
-0.19
-0.34
-0.74
-1.09
5.72
Tax Paid
-
-
-
-
-
-
-
-
0.77
Profit After Tax
-2.36
-0.16
-0.06
-0.18
-0.19
-0.34
-0.74
-1.09
4.96
Total Net profit including share of profit / Loss from associate company
-2.36
-0.16
-0.06
-0.18
-0.19
-0.34
-0.74
-1.09
4.96
EPS
-5.37
-0.38
-0.14
-0.41
-0.42
-0.77
-1.68
-0.99
2.09
Actual EPS
-5.37
-0.38
-0.14
-0.41
-0.42
-0.77
-1.68
-0.99
2.09
Adjusted EPS
-5.37
-0.38
-0.14
-0.41
-0.42
-0.77
-1.68
-0.99
2.09
Diluted EPS
-5.37
-0.38
-0.14
-0.41
-0.42
-0.77
-1.68
-0.99
2.09

Kabra Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.28
0.31
-0.12
-0.18
-0.05
-0.25
-0.13
-0.35
-0.21
-4.71
Cash Flow from Investing Activities
-0.29
0.01
1.5
0.07
0.06
-
-
-
-
-0.05
Cash Flow from Financing Activities
-0.27
-0.32
-1.35
-
-0.02
0.25
0.13
0.36
2.88
23.39
Net Cash Flow
-0.28
-
0.04
-0.1
-
-
-0.01
-
2.67
18.63

Kabra Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Kabra Drugs.

  • Kabra Drugs Ltd Earnings Results

    Kabra Drugs Ltd’s net profit jumped 171.79% since last year same period to ₹1.06Cr in the Q4 2025-2026. On a quarterly growth basis, Kabra Drugs Ltd has generated -58.75% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Kabra Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Kabra Drugs stock has moved up by 8.9%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 100.00% of holdings in Mar 2026 quarter

About Kabra Drugs Ltd

Kabra Drugs Ltd was incorporated in 1989 in Indore, Madhya Pradesh and later converted into a Public Limited Company in 1992. The company operates a unit for the manufacturing of Ether derivatives, such as Diethyl Ether Anesthesia Solvent Ether Ethyl Chloride Spray, General Anesthesia and Surgical. Additionally, the company released a range of disinfectants in the market, including hand wash gel, hand sanitizer, and antimicrobial gel, with it being the sole manufacturer of the last.
Kabra Drugs Ltd, has also registered itself as a supplier to the Ministry of Defence, and has designed a variety of new products for the global market. Having acquired experience in producing injectables, soft gelatin capsules, liquids oral and external, especially liquor-based products, the company is now looking to expand its customer base worldwide.

Revenue: ₹35.41Cr as on March 2026 (Q4 FY26)
Net Profit: ₹1.06Cr as on March 2026 (Q4 FY26)
OrganisationKabra Drugs Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Kabra Drugs share price today?

Kabra Drugs share price today stands at ₹26.89 as on at the close of the market. Kabra Drugs share today touched a day high of ₹28.35 and a low of ₹25.25.

What is the 52 week high and 52 week low range for Kabra Drugs share?

Kabra Drugs touched a 52 week high of ₹35.52 and a 52 week low of ₹12.21. Kabra Drugs share price today i.e. is closed at ₹26.89, which is -24.30% down from its 52 week high and 120.23% up from its 52 week low.

What is Kabra Drugs's market capitalisation today?

Kabra Drugs market capitalisation is ₹56.02 Cr as on .

How to buy Kabra Drugs shares?

To buy Kabra Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524322 or Kabra Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kabra Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kabra Drugs trading volume today?

Kabra Drugs trading volume is 3.66L as on . This means that 3.66L shares of Kabra Drugs were bought and sold on the stock market during today's trading session.